US 7517661
Methods of screening for ligands for FPRL2
granted A61KA61K38/177A61P
Quick answer
US patent 7517661 (Methods of screening for ligands for FPRL2) held by Takeda Pharmaceutical Company Limited expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/177, A61P, A61P1/04, A61P1/16